Tema: Re: Del poregistraciniu studiju
Autorius: ArunasM
Data: 2010-02-25 19:32:16
arba ne... kaip rodo realybe net ir 16, 18 tipams jau indikacijos 
skiriasi...


"CatBlack" <darius@asotra_nospam.lt> wrote in message 
news:hm60vu$vku$1@trimpas.omnitel.net...
> Tikriausiai:)
> "sooriz" <nera@mailo.lt> wrote in message
> news:hm5ut2$sfo$1@trimpas.omnitel.net...
> O Cervarix irgi ta pacia indikacija paims? :)
>
> "ArunasM" <aaa@ssss.com> wrote in message
> news:hm49u5$89v$1@trimpas.omnitel.net...
>> nujo.. ilgai reikejo mastyt...
>> http://www.merck.com/newsroom/news-release-archive/product/2010_0217.html
>>
>>
>>
>>
>> "CatBlack" <darius@asotra_no.spam.lt> wrote in message
>> news:hm3u91$tq0$1@trimpas.omnitel.net...
>>> Nu taigis zinome, zinome:)
>>>
>>> "ArunasM" <aaa@ssss.com> wrote in message
>>> news:hm3omp$nrv$1@trimpas.omnitel.net...
>>>> prekiaukit prekiaukit :)
>>>>
>>>> P.S.
>>>> Gardasil = Silgard
>>>>
>>>>
>>>> "CatBlack" <darius@asotra_nospam.lt> wrote in message
>>>> news:hm2t70$e5j$1@trimpas.omnitel.net...
>>>>> Studijos is tikruju vyksta - itraukiama vis daugiau potencialiu
>>>>> "vartotoju":
>>>>>
>>>>> "Merck & Co. announced Wednesday that results from two studies suggest
>>>>> that
>>>>> the company's human papillomavirus (HPV) vaccine Gardasil protected
>>>>> women
>>>>> aged 24 to 45 years from developing cervical cancer and homosexual men
>>>>> from
>>>>> developing anal cancer.Merck & Co. announced Wednesday that results
>>>>> from two
>>>>> studies suggest that the company's human papillomavirus (HPV) vaccine
>>>>> Gardasil protected women aged 24 to 45 years from developing cervical
>>>>> cancer
>>>>> and homosexual men from developing anal cancer."
>>>>>
>>>>>
>>>>
>>>>
>>>
>>>
>>
>>
>
>
>